Let’s start your search

Our Oligos Platform connects you with CDMOs that provide end-to-end support for oligonucleotide development. From early development—including formulation development—to delivery of research material for pharmacokinetic and proof-of-concept studies, our platform supports progression toward clinical and commercial programs.